Search the LJMU website

Search results filters

1. Amy Cunningham Start-up Case Study | Student Futures

   Amy Cunningham graduated in 2023 with a degree in Marketing and now runs her own marketing business called The Social Muze.

2. Clearing blog 2023

   Don’t think university is for you? Think again! LJMU’s caring community is here to support you to achieve your best.

3. Olivia Coles Graduate Case Study | Student Futures

   Olivia Coles is a video journalist at the Times and the Sunday Times in London. Olivia graduated from LJMU with a degree in History and English and then went on to do an MA in Broadcast Journalism at City University, London.

4. Groundhog Day or liberation from daily routine?

   Dr Ruth Odgen from the School of Psychology, a lead investigator on a new study into time under COVID-19 isolation, shares her thoughts with us.

5. Bridie Smith Graduate Case Study | Student Futures

   Bridie Smith graduated with a History degree and then went on to complete her graduate diploma in Law and a Legal Practice course at the University of Law before becoming a Paralegal for DWF.

6. My law field trip to a former prison at Lancaster Castle

   Second year LLB Law student Poppy shares what she learnt away from the lecture theatre about legal history during a visit to Lancaster.

7. Esma Esin Yildirim Eryilmaz Start-up Case Study | Student Futures

   Esma Esin Yildirim Eryilmaz graduated in 2024 with an MSc in Cosmetic Science and now runs her own business, Botanifolia, which makes and sells botanical wellbeing products.

8. What supplements do scientists use and why?

   Six scientists share their supplement recommendations.

9. Hattie Lowe Graduate Case Study | Student Futures

   Hattie Lowe graduated with a History degree and then went on to do a Masters at Chester University in Sustainable Heritage before securing a job as a Programming and Partnerships Officer for the National Trust.

10. Prescription drugs pregabalin and gabapentin have been reclassified – but it won’t stop problem use

    Prescription drugs pregabalin and gabapentin have been reclassified – but it won’t stop problem use